Santen Pharmaceutical Facilitates Compliance, Promotes Safety, and Supports Growth with Oracle Argus Cloud Service
Scalable Cloud-Based Solution Provides High Availability and IT Cost Predictability
Santen Pharmaceutical Co., Ltd. (Santen), a Japan-based pharmaceutical company specializing in ophthalmic and anti-rheumatoid arthritis products, wanted to centralize its pharmacovigilance and medical device safety processes to increase visibility into drug safety data and global regulatory compliance. To achieve those goals while maintaining high availability and gaining a predictable IT spend, the company deployed Oracle Argus Cloud Service. Working with Oracle Health Sciences Consulting, the pharmaceutical company was live on the solution in just 10 months.
News Facts
· To help ensure patient safety and improve its ability to enable real-time decisions about product portfolios, Santen is using Oracle Argus Cloud Service as its safety information platform.
· The company decided to implement Oracle Argus Cloud Service to manage its safety data and increase the efficiency of its pharma and medical device covigilance processes.
· With the help of Oracle Health Sciences Consulting, Santen migrated its legacy data and rolled out the Oracle Argus Cloud Service solution in just 10 months, despite complex regulatory compliance requirements.
· As a result, the company gained faster insight into potential safety issues as they arise.
· Santen also expects to be able to build safety management teams more rapidly and effectively when it expands to new regions across the globe.
· Taking advantage of Oracle Health Sciences Cloud also provides Santen with high availability, timely maintenance by specialists, and IT cost predictability.
· The company expects to roll out Oracle Argus Safety across its global business operations.
Supporting Quotes
· “Oracle Argus Cloud Service gave us the global consolidated platform we needed to improve safety information management. It also enabled IT cost predictability and streamlined the management and maintenance of our safety IT,” said Mitsuru Fukumoto, general manager, Safety Vigilance Group, Santen Pharmaceutical Co., Ltd.
· “With Oracle Argus Cloud Service, Santen has a centralized platform to manage safety data, which provides expanded insight, helps reduce risk, and eases regulatory reporting and compliance activities. These capabilities are bringing powerful advantages as the company continues to grow and transform its business practices,” said Steve Rosenberg, senior vice president and general manager, Oracle Health Sciences.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
